Dr. Peter Marks director of FDA Center for Biologics Evaluation and Research

2 Results / Page 1 of 1

Background

Health & Wellness

FDA puts strict limits on Johnson & Johnson Covid-19 vaccine

As CNN reports, the US Food and Drug Administration announced last week that it is limiting the emergency use authorization of the Johnson & Johnson/Janssen Covid-19 vaccine to people 18 and older for whom other vaccines aren't appropriate or accessible and those who opt for J&J because they wouldn't otherwise get vaccinated. The FDA said in a statement that the change is being made because of the risk of a rare and […]

todayMay 11, 2022

Health & Wellness

FDA Authorizes Second Covid-19 Booster Shots for People Over 50

The US Food and Drug Administration (FDA) has expanded the emergency use authorization of the Pfizer and Moderna Covid-19 vaccines to allow adults 50 and older to get a second booster as early as four months after their first booster dose of any Covid-19 vaccine, as reported by CNN. The move extends the availability of additional boosters to healthy older adults. The FDA had previously allowed additional shots for anyone […]

todayMarch 30, 2022

Subscribe

LISTEN WITH YOUR APP

0%